Search Results

240 results for OKS

Xerox Is an AI Trap — This Company Is a Better “Match”

In today’s Smart Money, I’ll look at a company that highlights the limits of legacy AI Appliers struggling to adapt as A-AI accelerates. Then, I’ll…

Not Even a Good Earnings Report Makes Citigroup Stock Interesting

Citigroup earnings, like Citigroup stock, look OK but not compelling

BioMimetic Has Suitors Lying in Wait

A key FDA OK could have the buyout offers rolling in.

It’s OK to Bank on Bankrate

A weak Bankrate earnings report doesn’t seem to be bothering investors, who instead seem to be bullish about the company’s future prospects.

Regional Bank Stocks – 2 Ways to Short Bank Stocks

While the big investment banks may be OK, regional banks are in for a rough third quarter.

3 Regional Banks That Slayed Q2 Earnings

The big banks are doing OK on earnings, but regional banks such as BancFirst (BANF) are absolutely crushing it.

It’s OK to be an Opportunist Investor in Amazon

Amazon has shown no limits thus far so AMZN stock is headed higher. Meanwhile, dare to be a confident bull and an opportunist investor.

Nio Is a Momentum Stock and That’s OK

With China’s electric vehicle market on the upswing, Nio stock has the makings of a long-term winner despite more than quadrupling this year.

Aeropostale Wins OK to Sell Assets

Aeropostale has gained approval from a bankruptcy judge to sell its assets to a group of landlords. The deal is worth about $243 million.

Fossil: Not Exactly Luxury — And That’s OK

Fossil offers a mix of both appreciated brand name and respectable prices, meaning it should continue its earnings growth amid a wobbly economy.

Another Loss, But It’ll Be OK

With proper discipline, technical analysis will prove to be a valuable tool in navigating through the market’s soon-to-come vibrations.

It’s the Season of Hope

A modest rise in oil prices along with some momentum in the markets has us looking towards a hopeful 2016

‘OK Google’ Voice Command No Longer Available on Chrome

Google is no longer allowing some Chrome users to use “OK Google” voice commands due to it not being a very popular feature.

Ocugen Stock Is Not One to Trust With Nest Egg Funds

There is too much riding on hope for OCGN stock. It is OK to trade it but fundamental investments are too risky for most.

Twitter Stock as Unpopular With Traders as It Is With Users

Twitter earnings were OK, but user growth slowed yet again. That ultimately will mean the death of TWTR stock.

RadioShack’s Liquidity Looks a Little Dry

RadioShack addressed reports that it was talking to investment bankers by announcing it was fine on the liquidity front. But is RSH really OK?

What’s Next for Apple Stock? $600 … or $400?

Counterintuitive as it might be, the fact that analysts have gone sour on Apple stock might be the best indication that AAPL will be OK.

3 High-Yield MLPs to Pump Into Your Portfolio

There are still a few high-yielding MLPs worth buying. EEP, HEP and OKS are three MLPs that make the cut and are worth adding to…

It’s OK to Sell the News on Ocugen and Covaxin

OCGN stock jumped when Covaxin received WHO approval. But with two major obstacles in the way of U,S. approval, you should sell the news.

OK Boomer, Flexion Stock Is Made For You

FLXN stock has been falling because the company is not in the race for a Covid-19 vaccine. But as that field narrows, FLX is worth…

Tesla Delays 10-K, But It’s OK

Tesla Motors indicated mistakes in its capital expenditure accounting, but it won’t have an impact on Tesla’s previously reported numbers — or the stock’s momentum.

McDonald’s: Nothing Novel (And That’s OK!)

As its Mighty Wings illustrate, McDonald’s is like Microsoft in that it doesn’t create — it just copies and institutionalizes. But more often than not,…

FDA Considers Giving OK for OTC Singulair

Drug company Merck is looking for approval from the Food and Drug Administration to start selling its Singulair over the counter.

Book Publishing Giants Get OK to Merge

The merger between Bertelsmann’s Random House and Pearson’s Penguin has received approval from the European Commission.

1 – 10 of 240 results